Laboratory operator Labcorp (LH.N) raised its annual profit forecast and posted better-than-expected second-quarter results on Thursday, as steady demand for diagnostic testing and growth in its drug-development services business boosted performance.
Shares of the company rose about 1% in morning trading, reversing premarket losses.
Here are more details:
